期刊
ACTA NEUROPATHOLOGICA
卷 142, 期 2, 页码 243-257出版社
SPRINGER
DOI: 10.1007/s00401-021-02318-y
关键词
Tau; Immunotherapy; Gosuranemab; Astrocytic tau; Astrocyte; Microglia
资金
- National Institutes of Health [R01NS095792, R56AG063344, P01AG066597, P01AG010124, P30AG072979, U54NS115322, U19AG062418]
The study found that Gosuranemab treatment did not lead to clearance of neuropathologic FTLD-tau inclusions, but did induce changes including the presence of perivascular vesicular astrocytes (PVA) with tau accumulation within lysosomes. These results suggest that Gosuranemab may be associated with a glial response involving tau accumulation within astrocytic lysosomes.
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are neuropathologic subtypes of frontotemporal lobar degeneration with tau inclusions (FTLD-tau), primary tauopathies in which intracellular tau aggregation contributes to neurodegeneration. Gosuranemab (BIIB092) is a humanized monoclonal antibody that binds to N-terminal tau. While Gosuranemab passive immunotherapy trials for PSP failed to demonstrate clinical benefit, Gosuranemab reduced N-terminal tau in the cerebrospinal fluid of transgenic mouse models and PSP patients. However, the neuropathologic sequelae of Gosuranemab have not been described. In this present study, we examined the brain tissue of three individuals who received Gosuranemab. Post-mortem human brain tissues were studied using immunohistochemistry to identify astrocytic and microglial differences between immunized cases and a cohort of unimmunized PSP, CBD and aging controls. Gosuranemab immunotherapy was not associated with clearance of neuropathologic FTLD-tau inclusions. However, treatment-associated changes were observed including the presence of perivascular vesicular astrocytes (PVA) with tau accumulation within lysosomes. PVAs were morphologically and immunophenotypically distinct from the tufted astrocytes seen in PSP, granular fuzzy astrocytes (GFA) seen in aging, and astrocytic plaques seen in CBD. Additional glial responses included increased reactive gliosis consisting of bushy astrocytosis and accumulation of rod microglia. Together, these neuropathologic findings suggest that Gosuranemab may be associated with a glial response including accumulation of tau within astrocytic lysosomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据